Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

PJ Online | News (13 August 2005)

Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 275 No 7362 p193
13 August 2005

This section
Reprint   Photocopy

PDF 450K, Acrobat Reader

News summary

DIARY   Branch meetings   Future Events   Conferences

183 Codeine and dihydrocodeine limited to 32 per pack Pharmacy packs of analgesics containing codeine or dihydrocodeine are to be limited to a maximum pack size of 32 and new warnings are to be added to the patient information leaflets, the Medicines and Healthcare products Regulatory Agency has announced ...more

183 Concerns raised over communication on national programme for IT Concerns by senior NHS managers about the progress of the national programme for IT are highlighted in an article published in the BMJ ...more

183 Changes to professional regulation must be evidence based Changes made to the regulation of health care professionals need to be based on appropriate evidence, the Council for Healthcare Regulatory Excellence said this week ...more

183 Society plans to introduce concessionary retention fees Reduced retention fees for long-serving retired pharmacists and for most overseas pharmacists are included in the Royal Pharmaceutical Society’s proposed fee structure for 2006 ...more

184 SMC endorses use of a further seven medicines Seven medicines, including the colon cancer treatment capecitabine (Xeloda), were approved for use within NHS Scotland by the Scottish Medicines Consortium this week ...more

184 Bug busting more effective than insecticides Use of the Bug Buster kit is four times more effective at eliminating head lice than use of two over-the-counter insecticides, a study has found ...more

184 Flaws revealed in Alzheimer’s disease trials Recommendations on the use of cholinesterase inhibitors in dementia have a questionable scientific basis, according to a review in last week’s BMJ ...more

184 Routine vitamin and mineral supplementation in elderly does not reduce infections Further evidence to suggest that routine use of multivitamin and mineral supplements in elderly patients living at home does not reduce infections was published last week ...more

185 Scotland’s e-pharmacy programme moves forward Progress in the development of IT to support the new pharmacy contract in Scotland means that the four core services of the contract will be phased in as IT to support them becomes available. Implementation is still on track to begin in April 2006 ...more

185 Substance misuse could be tackled through new contract Substance misuse treatment programmes in Scotland could be improved if NHS boards make use of the new community pharmacy contract ...more

185 Guidance issued on declaring dispensing process hours In order to make it easier for contractors in England and Wales to fill in details of dispensing staff on the FP34C submission form, the Department of Health and the Pharmaceutical Services Negotiating Committee last week issued a statement explaining the dispensing staff declaration ...more

185 Poor analgesia standards in A&E The Healthcare Commission has revealed that 47 per cent of children and 58 per cent of adults with fractures are not offered pain relief within an hour of arrival at accident and emergency departments ...more

185 Welsh STI campaign Awareness of sexually transmitted infections is the theme of a health campaign launched by the Welsh Assembly Government last week ...more

185 Prescription refunds A new version of the FP57 NHS prescription charges receipt form has been made available in Scotland ...more

186 Updated guidelines for first-line treatment of HIV Updated guidelines, published last week by the British HIV Association, review recent clinical trial data and provide clearer advice on which nucleoside backbone combinations should be used as first-line treatment in HIV patients ...more

186 Switching to anastrozole has benefits for breast cancer patients Switching to anastrozole (Arimidex) after two years’ treatment with tamoxifen results in a 40 per cent reduction in the risk of relapse for postmenopausal women with early breast cancer, compared with continuing tamoxifen for five years, a Lancet paper has shown ...more

186 HAART reduces rate of progression to AIDS Highly active antiretroviral therapy (HAART) can reduce the rate of progression to AIDS or death by 86 per cent in HIV patients, researchers have found, and the therapy becomes more effective over time ...more

186 Newer antiemetics not always used effectively Selective 5HT3-receptor antagonists are not always used effectively as antiemetics in the treatment of cancer patients, a review in this month’s Drug and Therapeutics Bulletin argues ...more


R&D NEWS

187 DNA vaccine against bird flu to enter trials next year Next year will see the start of clinical trials of a vaccine against avian influenza, a UK company announced this week ...more

187 Genetically modified probiotic could protect against HIV infection Naturally occurring bacteria that have been genetically modified to protect against HIV infection have been successfully tested in mice, according to US researchers ...more

188 Transdermal testosterone patch increases sexual desire in women after surgical menopause A transdermal patch that delivers 300µg of testosterone daily produces modest increases in sexual desire in women who have undergone surgical menopause, according to a new study ...more

188 Amphetamine derivatives could be useful in treating Parkinson’s disease symptoms Amphetamine-type drugs may be beneficial for treating symptoms of Parkinson’s disease, according to new data from the US ...more

188 Cannabis relief in IBD Scientists investigating anecdotal evidence that patients with inflammatory bowel disease (IBD) find relief from using cannabis have found a possible explanation for this effect ...more

188 Nanocell drug delivery shows cancer treatment promise Problems delivering chemotherapy to cancer cells along with drugs that inhibit blood vessel growth may be overcome by the use of nanotechnology ...more

188 Gefitinib resistance marker Researchers have identified a protein — epithelial membrane protein-1 — whose expression in tumour cells correlates with resistance to gefitinib (Iressa) ...more

Back to Top


©The Pharmaceutical Journal

Citation: The Pharmaceutical Journal URI: 20015372

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

RPS publications

Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.

Visit rpharms.com

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Rate
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.